What is Jazz Pharmaceuticals, Inc.'s Market Cap?

Jazz Pharmaceuticals, Inc.'s Market Cap is $15.6B, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s Enterprise Value?

Jazz Pharmaceuticals, Inc.'s Enterprise Value is $18.4B, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s Trailing P/E?

Jazz Pharmaceuticals, Inc.'s Trailing P/E is 16.6×, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s Price / Sales?

Jazz Pharmaceuticals, Inc.'s Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s EV / Revenue?

Jazz Pharmaceuticals, Inc.'s EV / Revenue is 4.0×, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s EV / EBITDA?

Jazz Pharmaceuticals, Inc.'s EV / EBITDA is 19.5×, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s Revenue (TTM)?

Jazz Pharmaceuticals, Inc.'s Revenue (TTM) is $4.6B, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s Net Income (TTM)?

Jazz Pharmaceuticals, Inc.'s Net Income (TTM) is $940.8M, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s EBITDA?

Jazz Pharmaceuticals, Inc.'s EBITDA is $938.5M, based on as-reported figures from SEC (XBRL) filings.

What is Jazz Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

Jazz Pharmaceuticals, Inc.'s Diluted EPS (TTM) is 14.49, based on as-reported figures from SEC (XBRL) filings.

Jazz Pharmaceuticals, Inc. (JAZZ) Financial Statements

Jazz Pharmaceuticals, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SNW8K1

XNAS · usd

240.82▲ 0.75 (0.31%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close240.07

Day's Range239.11 – 244.71

52-Week Range123.88 – 266.38

Volume467.5K

Avg Volume981.2K

Share Statistics

Shares Outstanding

Employees2,890

ExchangeXNAS

Listed2007-06-01

Share count as of July 27, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Jazz Pharmaceuticals, Inc. (JAZZ)

What is Jazz Pharmaceuticals, Inc.'s Market Cap?: Jazz Pharmaceuticals, Inc.'s Market Cap is $15.6B, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s Enterprise Value?: Jazz Pharmaceuticals, Inc.'s Enterprise Value is $18.4B, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s Trailing P/E?: Jazz Pharmaceuticals, Inc.'s Trailing P/E is 16.6×, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s Price / Sales?: Jazz Pharmaceuticals, Inc.'s Price / Sales is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s EV / Revenue?: Jazz Pharmaceuticals, Inc.'s EV / Revenue is 4.0×, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s EV / EBITDA?: Jazz Pharmaceuticals, Inc.'s EV / EBITDA is 19.5×, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s Revenue (TTM)?: Jazz Pharmaceuticals, Inc.'s Revenue (TTM) is $4.6B, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s Net Income (TTM)?: Jazz Pharmaceuticals, Inc.'s Net Income (TTM) is $940.8M, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s EBITDA?: Jazz Pharmaceuticals, Inc.'s EBITDA is $938.5M, based on as-reported figures from SEC (XBRL) filings.
What is Jazz Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: Jazz Pharmaceuticals, Inc.'s Diluted EPS (TTM) is 14.49, based on as-reported figures from SEC (XBRL) filings.